{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:31:51Z","timestamp":1791952311097,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11883-021-00973-w","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T03:40:46Z","timestamp":1634787646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-6244","authenticated-orcid":false,"given":"Bahar","family":"Behrouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7402-9584","authenticated-orcid":false,"given":"Jacob A.","family":"Udell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"973_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5469","author":"FB Ahmad","year":"2021","unstructured":"Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021. https:\/\/doi.org\/10.1001\/jama.2021.5469.","journal-title":"JAMA"},{"key":"973_CR2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.2021.5120","volume":"325","author":"AM Garber","year":"2021","unstructured":"Garber AM. Learning from excess pandemic deaths. JAMA. 2021;325:1729.","journal-title":"JAMA"},{"key":"973_CR3","doi-asserted-by":"crossref","unstructured":"Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731.","DOI":"10.1136\/bmj.m3731"},{"key":"973_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.28.21256","author":"JA Udell","year":"2021","unstructured":"Udell JA, Behrouzi B, Sivaswamy A, et al. Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada. medRxiv Prepr. 2021. https:\/\/doi.org\/10.1101\/2021.04.28.21256.","journal-title":"medRxiv Prepr"},{"key":"973_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jiz570","volume":"221","author":"TA Walker","year":"2020","unstructured":"Walker TA, Waite B, Thompson MG, et al. Risk of severe influenza among adults with chronic medical conditions. J Infect Dis. 2020;221:183\u201390.","journal-title":"J Infect Dis"},{"key":"973_CR6","doi-asserted-by":"crossref","first-page":"e0214517","DOI":"10.1371\/journal.pone.0214517","volume":"14","author":"R Cohen","year":"2019","unstructured":"Cohen R, Babushkin F, Geller K, Finn T. Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and respiratory syncytial virus \u2013 a single center retrospective observational study. PLoS One. 2019;14:e0214517.","journal-title":"PLoS One"},{"key":"973_CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/M20-1509","volume":"173","author":"EJ Chow","year":"2020","unstructured":"\u2022\u2022 Chow EJ, Rolfes MA, O\u2019Halloran A, et al. Acute cardiovascular events associated with influenza in hospitalized adults. Ann Intern Med. 2020;173:605\u201313 This is a cross-sectional study of FluSurv-NET to determine risk factors for acute HF and acute ischemic heart disease in adults with a hospitalization associated with laboratory-confirmed influenza.","journal-title":"Ann Intern Med"},{"key":"973_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa730","author":"N Prasad","year":"2020","unstructured":"Prasad N, Walker TA, Waite B, et al. Respiratory syncytial virus\u2013associated hospitalizations among adults with chronic medical conditions. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa730.","journal-title":"Clin Infect Dis"},{"key":"973_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcv.2019.07.001","volume":"117","author":"B Chuaychoo","year":"2019","unstructured":"Chuaychoo B, Ngamwongwan S, Kaewnaphan B, Athipanyasilp N, Horthongkham N, Kantakamalakul W, Muangman N. Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J Clin Virol. 2019;117:103\u20138.","journal-title":"J Clin Virol"},{"key":"973_CR10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","volume":"71","author":"KS Ivey","year":"2018","unstructured":"Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71:1574\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"973_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","author":"M Madjid","year":"2020","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.1286.","journal-title":"JAMA Cardiol"},{"key":"973_CR12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2020.08.028","volume":"76","author":"B Behrouzi","year":"2020","unstructured":"\u2022 Behrouzi B, Araujo Campoverde MV, Liang K, et al. Influenza vaccination to reduce cardiovascular morbidity and mortality in patients with COVID-19. J Am Coll Cardiol. 2020;76:1777\u201394 This narrative review provides a thorough summary of landmark studies assessing the association between influenza and CVD, as well as the cardioprotective effects of influenza vaccine.","journal-title":"J Am Coll Cardiol"},{"key":"973_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378:345\u201353.","journal-title":"N Engl J Med"},{"key":"973_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","volume":"10","author":"VF Corrales-Medina","year":"2010","unstructured":"Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10:83\u201392.","journal-title":"Lancet Infect Dis"},{"key":"973_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","volume":"9","author":"C Warren-Gash","year":"2009","unstructured":"Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601\u201310.","journal-title":"Lancet Infect Dis"},{"key":"973_CR16","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","volume":"351","author":"L Smeeth","year":"2004","unstructured":"Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611\u20138.","journal-title":"N Engl J Med"},{"key":"973_CR17","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2307\/4580606","volume":"47","author":"S Collins","year":"1932","unstructured":"Collins S. Excess mortality from causes other than influenza and pneumonia during influenza epidemic. Public Health Rep. 1932;47:2159\u201379.","journal-title":"Public Health Rep"},{"key":"973_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179.","journal-title":"JAMA"},{"key":"973_CR19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","volume":"292","author":"WW Thompson","year":"2004","unstructured":"Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. J Am Med Assoc. 2004;292:1333.","journal-title":"J Am Med Assoc"},{"key":"973_CR20","unstructured":"Centers for Diseases Control and Prevention (CDC). Flu & people with heart disease or history of stroke. In: Who is High Risk Flu Complicat. 2021. https:\/\/www.cdc.gov\/flu\/highrisk\/heartdisease.htm. Accessed 29 Mar 2021."},{"key":"973_CR21","unstructured":"Centers for Diseases Control and Prevention (CDC). Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States \u2014 2019\u20132020 influenza season. 2020. https:\/\/www.cdc.gov\/flu\/about\/burden\/2019-2020.html#:~:text=CDC%20estimates%20that%20the%20burden,flu%20deaths (Table 1).\u00a0Accessed 7 July 2021."},{"key":"973_CR22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391:1285\u2013300.","journal-title":"Lancet"},{"key":"973_CR23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","volume":"11","author":"SA Sellers","year":"2017","unstructured":"Sellers SA, Hagan RS, Hayden FG, Fischer WA. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respi Viruses. 2017;11:372\u201393.","journal-title":"Influenza Other Respi Viruses"},{"key":"973_CR24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.15585\/mmwr.mm6722a4","volume":"67","author":"R Garten","year":"2018","unstructured":"Garten R, Blanton L, Elal AIA, et al. Update: influenza activity in the United States during the 2017\u201318 season and composition of the 2018\u201319 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2018;67:634\u201342.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"973_CR25","unstructured":"Centers for Diseases Control and Prevention (CDC). Flu activity & surveillance. 2020. https:\/\/www.cdc.gov\/flu\/weekly\/fluactivitysurv.htm.\u00a0Accessed 7 July 2021."},{"key":"973_CR26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7326\/L21-0017","volume":"174","author":"A Schattner","year":"2021","unstructured":"Schattner A. Acute cardiovascular events associated with influenza in hospitalized adults. Ann Intern Med. 2021;174:583.","journal-title":"Ann Intern Med"},{"key":"973_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12872-015-0095-0","volume":"15","author":"A Ludwig","year":"2015","unstructured":"Ludwig A, Lucero-Obusan C, Schirmer P, Winston C, Holodniy M. Acute cardiac injury events \u226430 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010\u20132012. BMC Cardiovasc Disord. 2015;15:109.","journal-title":"BMC Cardiovasc Disord"},{"key":"973_CR28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","volume":"13","author":"T-Y Chang","year":"2016","unstructured":"Chang T-Y, Chao T-F, Liu C-J, Chen S-J, Chung F-P, Liao J-N, Tuan T-C, Chen T-J, Chen S-A. The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study. Hear Rhythm. 2016;13:1189\u201394.","journal-title":"Hear Rhythm"},{"key":"973_CR29","doi-asserted-by":"crossref","first-page":"e0118369","DOI":"10.1371\/journal.pone.0118369","volume":"10","author":"C Reed","year":"2015","unstructured":"Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10:e0118369.","journal-title":"PLoS One"},{"key":"973_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/EDE.0b013e31816a4325","volume":"19","author":"A Schneider","year":"2008","unstructured":"Schneider A, Panagiotakos D, Picciotto S, et al. Air temperature and inflammatory responses in myocardial infarction survivors. Epidemiology. 2008;19:391\u2013400.","journal-title":"Epidemiology"},{"key":"973_CR31","doi-asserted-by":"crossref","first-page":"c3823","DOI":"10.1136\/bmj.c3823","volume":"341","author":"K Bhaskaran","year":"2010","unstructured":"Bhaskaran K, Hajat S, Haines A, Herrett E, Wilkinson P, Smeeth L. Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry. BMJ. 2010;341:c3823\u2013c3823.","journal-title":"BMJ"},{"key":"973_CR32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jir171","volume":"203","author":"C Warren-Gash","year":"2011","unstructured":"Warren-Gash C, Bhaskaran K, Hayward A, Leung GM, Lo S-V, Wong C-M, Ellis J, Pebody R, Smeeth L, Cowling BJ. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis. 2011;203:1710\u20138.","journal-title":"J Infect Dis"},{"key":"973_CR33","doi-asserted-by":"crossref","first-page":"1701794","DOI":"10.1183\/13993003.01794-2017","volume":"51","author":"C Warren-Gash","year":"2018","unstructured":"Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018;51:1701794.","journal-title":"Eur Respir J"},{"key":"973_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cid\/cix1144","volume":"67","author":"R Blackburn","year":"2018","unstructured":"Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004\u20132015. Clin Infect Dis. 2018;67:8\u201317.","journal-title":"Clin Infect Dis"},{"key":"973_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamacardio.2019.0549","volume":"4","author":"S Kyt\u00f6maa","year":"2019","unstructured":"Kyt\u00f6maa S, Hegde S, Claggett B, Udell JA, Rosamond W, Temte J, Nichol K, Wright JD, Solomon SD, Vardeny O. Association of influenza-like illness activity with hospitalizations for heart failure. JAMA Cardiol. 2019;4:363.","journal-title":"JAMA Cardiol"},{"key":"973_CR36","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.17.1900199","author":"J Ohland","year":"2020","unstructured":"Ohland J, Warren-Gash C, Blackburn R, M\u00f8lbak K, Valentiner-Branth P, Nielsen J, Emborg H-D. Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016. Eurosurveillance. 2020. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.17.1900199.","journal-title":"Eurosurveillance"},{"key":"973_CR37","doi-asserted-by":"crossref","unstructured":"Garc\u00eda\u2010Lled\u00f3 A, Rodr\u00edguez\u2010Mart\u00edn S, Tob\u00edas A, Garc\u00eda\u2010de\u2010Santiago E, Ordob\u00e1s\u2010Gav\u00edn M, Ansede\u2010Cascudo JC, Alonso\u2010Mart\u00edn J, de Abajo FJ. Relationship between influenza, temperature, and type 1 myocardial infarction: An ecological time\u2010series study. J Am Heart Assoc. 2021;10:e019608.","DOI":"10.1161\/JAHA.120.019608"},{"key":"973_CR38","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","volume":"310","author":"JA Udell","year":"2013","unstructured":"Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients. JAMA. 2013;310:1711.","journal-title":"JAMA"},{"key":"973_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005050.pub3","author":"C Clar","year":"2015","unstructured":"Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD005050.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"973_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.06.003","author":"BS Rodrigues","year":"2020","unstructured":"Rodrigues BS, Alves M, Duarte GS, Costa J, Pinto FJ, Caldeira D. The impact of influenza vaccination in patients with cardiovascular disease: an overview of systematic reviews. Trends Cardiovasc Med. 2020. https:\/\/doi.org\/10.1016\/j.tcm.2020.06.003.","journal-title":"Trends Cardiovasc Med"},{"key":"973_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019636","author":"SH Yedlapati","year":"2021","unstructured":"Yedlapati SH, Khan SU, Talluri S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2021. https:\/\/doi.org\/10.1161\/JAHA.120.019636.","journal-title":"J Am Heart Assoc"},{"key":"973_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036788","author":"D Modin","year":"2019","unstructured":"Modin D, J\u00f8rgensen ME, Gislason G, Jensen JS, K\u00f8ber L, Claggett B, Hegde SM, Solomon SD, Torp-Pedersen C, Biering-S\u00f8rensen T. Influenza vaccine in heart failure: cumulative number of vaccinations, frequency, timing, and survival: a Danish nationwide cohort study. Circulation. 2019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036788.","journal-title":"Circulation"},{"key":"973_CR43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"MD Flather","year":"2000","unstructured":"Flather MD, Yusuf S, K\u00f8ber L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 2000;355:1575\u201381.","journal-title":"Lancet"},{"key":"973_CR44","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","volume":"150","author":"FA McAlister","year":"2009","unstructured":"McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: \u03b2-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150:784.","journal-title":"Ann Intern Med"},{"key":"973_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer. Circulation. 2017. https:\/\/doi.org\/10.1161\/CIR.0000000000000509.","journal-title":"Circulation"},{"key":"973_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.07.001","author":"B Behrouzi","year":"2020","unstructured":"Behrouzi B, Udell JA. Influenza vaccine as part of a heart disease armamentarium in the new cardio-respiratory virus era. Trends Cardiovasc Med. 2020. https:\/\/doi.org\/10.1016\/j.tcm.2020.07.001.","journal-title":"Trends Cardiovasc Med"},{"key":"973_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01960","author":"T Fulop","year":"2018","unstructured":"Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, Witkowski JM, Franceschi C. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2017.01960.","journal-title":"Front Immunol"},{"key":"973_CR48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576\u201390.","journal-title":"Nat Rev Endocrinol"},{"key":"973_CR49","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cardfail.2008.11.009","volume":"15","author":"O Vardeny","year":"2009","unstructured":"Vardeny O, Sweitzer NK, Detry MA, Moran JM, Johnson MR, Hayney MS. Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail. 2009;15:368\u201373.","journal-title":"J Card Fail"},{"key":"973_CR50","doi-asserted-by":"crossref","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","volume":"13","author":"NC Wu","year":"2017","unstructured":"Wu NC, Zost SJ, Thompson AJ, Oyen D, Nycholat CM, McBride R, Paulson JC, Hensley SE, Wilson IA. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLOS Pathog. 2017;13:e1006682.","journal-title":"PLOS Pathog"},{"key":"973_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","volume":"378","author":"CI Paules","year":"2018","unstructured":"Paules CI, Sullivan SG, Subbarao K, Fauci AS. Chasing seasonal influenza \u2014 the need for a universal influenza vaccine. N Engl J Med. 2018;378:7\u20139.","journal-title":"N Engl J Med"},{"key":"973_CR52","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"SJ Zost","year":"2017","unstructured":"Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci. 2017;114:12578\u201383.","journal-title":"Proc Natl Acad Sci"},{"key":"973_CR53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","volume":"27","author":"R Nachbagauer","year":"2021","unstructured":"Nachbagauer R, Feser J, Naficy A, et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nat Med. 2021;27:106\u201314.","journal-title":"Nat Med"},{"key":"973_CR54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov. 2015;14:167\u201382.","journal-title":"Nat Rev Drug Discov"},{"key":"973_CR55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","volume":"371","author":"CA DiazGranados","year":"2014","unstructured":"DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635\u201345.","journal-title":"N Engl J Med"},{"key":"973_CR56","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurjhf\/hfs207","volume":"15","author":"A Van Ermen","year":"2013","unstructured":"Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail. 2013;15:560\u20134.","journal-title":"Eur J Heart Fail"},{"key":"973_CR57","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2015.07.006","volume":"33","author":"CA DiazGranados","year":"2015","unstructured":"DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP. Prevention of serious events in adults 65 years of age or older: a comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine. 2015;33:4988\u201393.","journal-title":"Vaccine"},{"key":"973_CR58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2018.05.007","volume":"202","author":"O Vardeny","year":"2018","unstructured":"Vardeny O, Udell JA, Joseph J, et al. High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: rationale and design of the INVESTED trial. Am Heart J. 2018;202:97\u2013103.","journal-title":"Am Heart J"},{"key":"973_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab133","author":"AS Bhatt","year":"2021","unstructured":"Bhatt AS, Vardeny O, Udell JA, Joseph J, Kim K, Solomon SD. Influenza vaccination: a \u2018shot\u2019 at INVESTing in cardiovascular health. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehab133.","journal-title":"Eur Heart J"},{"key":"973_CR60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","volume":"325","author":"O Vardeny","year":"2021","unstructured":"\u2022\u2022 Vardeny O, Kim K, Udell JA, et al. Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease. JAMA. 2021;325:39 These are the recent results of the first large influenza vaccine cardiovascular outcome trial, INVESTED, in patients with high-risk CVD, including previous MI and HF hospitalizations.","journal-title":"JAMA"},{"key":"973_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.03.007","author":"R Hollingsworth","year":"2021","unstructured":"\u2022\u2022 Hollingsworth R, Palmu A, Pepin S, Dupuy M, Shrestha A, Jokinen J, Syrj\u00e4nen R, Nealon J, Samson S, De Bruijn I. Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: rationale and design of a real-world pragmatic randomized clinical trial. Am Heart J. 2021. https:\/\/doi.org\/10.1016\/j.ahj.2021.03.007This is the design of the newest large influenza vaccine cardiovascular outcome (registry-based) trial, conducted by the Finnish Institute for Health and Welfare, in patients aged 65 and up.","journal-title":"Am Heart J"},{"key":"973_CR62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2017.04.003","volume":"189","author":"O Fr\u00f6bert","year":"2017","unstructured":"\u2022 Fr\u00f6bert O, G\u00f6tberg M, Anger\u00e5s O, et al. Design and rationale for the influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. Am Heart J. 2017;189:94\u2013102 This is the design of the first registry-based, large influenza vaccine cardiovascular outcome trial in patients with acute coronary syndrome undergoing coronary angiography.","journal-title":"Am Heart J"},{"key":"973_CR63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2019.02.009","volume":"212","author":"M Loeb","year":"2019","unstructured":"\u2022 Loeb M, Dokainish H, Dans A, et al. Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): rationale and design. Am Heart J. 2019;212:36\u201344 This is the design of a large influenza vaccine cardiovascular outcome trial in patients with HF.","journal-title":"Am Heart J"},{"key":"973_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","volume":"69","author":"LA Grohskopf","year":"2020","unstructured":"Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, Atmar RL. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2020\u201321 Influenza Season. MMWR Recomm Reports. 2020;69:1\u201324.","journal-title":"MMWR Recomm Reports"},{"key":"973_CR65","unstructured":"Nyl\u00e9n G, Linde A, Kettis AA, Wik O, Stenmark S, Erntell M. Health personnel the key to high vaccination coverage against influenza. Lakartidningen. 109:8\u20139"},{"key":"973_CR66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505\u201322.","journal-title":"Nat Rev Cardiol"},{"key":"973_CR67","doi-asserted-by":"crossref","unstructured":"Laurie KL, Rockman S. Which influenza viruses will emerge following the SARS\u2010CoV\u20102 pandemic? Influenza Other Respi Viruses. 2021;15:573\u2013576.","DOI":"10.1111\/irv.12866"},{"key":"973_CR68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2016.11.013","volume":"35","author":"B Young","year":"2017","unstructured":"Young B, Zhao X, Cook AR, Parry CM, Wilder-Smith A, I-Cheng MC. Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. Vaccine. 2017;35:212\u201321.","journal-title":"Vaccine"},{"key":"973_CR69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCULATIONAHA.120.049118","volume":"142","author":"PL Myhre","year":"2020","unstructured":"Myhre PL, Grundvold I, Paulsen TH, Omland T, Schirmer H. Cardiovascular hospitalizations, influenza activity, and COVID-19 measures. Circulation. 2020;142:1302\u20134.","journal-title":"Circulation"},{"key":"973_CR70","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.amepre.2015.06.008","volume":"50","author":"AC O\u2019Halloran","year":"2016","unstructured":"O\u2019Halloran AC, Lu P, Williams WW, Bridges CB, Singleton JA. Influenza vaccination coverage among people with high-risk conditions in the U.S. Am J Prev Med. 2016;50:e15\u201326.","journal-title":"Am J Prev Med"},{"key":"973_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","volume":"68","author":"LA Grohskopf","year":"2019","unstructured":"Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2019\u201320 Influenza Season. MMWR Recomm Rep. 2019;68:1\u201321.","journal-title":"MMWR Recomm Rep"},{"key":"973_CR72","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","volume":"113","author":"SC Smith","year":"2006","unstructured":"Smith SC, Allen J, Blair SN, et al. AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update. Circulation. 2006;113:2363\u201372.","journal-title":"Circulation"},{"key":"973_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.3978","author":"GR Grandhi","year":"2020","unstructured":"Grandhi GR, Mszar R, Vahidy F, Valero-Elizondo J, Blankstein R, Blaha MJ, Virani SS, Andrieni JD, Omer SB, Nasir K. Sociodemographic disparities in influenza vaccination among adults with atherosclerotic cardiovascular disease in the United States. JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.3978.","journal-title":"JAMA Cardiol"},{"key":"973_CR74","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.3983","author":"LS Sperling","year":"2020","unstructured":"Sperling LS, Albert MA, Koppaka R. Disparities in influenza vaccination\u2014opportunity to extend cardiovascular prevention to millions of hearts. JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.3983.","journal-title":"JAMA Cardiol"},{"key":"973_CR75","unstructured":"WHO (World Health Organization). Ten threats to global health in 2019. 2019. https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019.\u00a0Accessed 7 July 2021."},{"key":"973_CR76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225\u20138.","journal-title":"Nat Med"},{"key":"973_CR77","unstructured":"WHO (World Health Organization). Report of the SAGE working group on vaccine hesitancy. 2014. https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.\u00a0Accessed 7 July 2021."},{"key":"973_CR78","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.pec.2019.12.008","volume":"103","author":"A Schattner","year":"2020","unstructured":"Schattner A. Cardiovascular-targeted patient education and uptake of influenza vaccination in elderly patients. Patient Educ Couns. 2020;103:1052\u20134.","journal-title":"Patient Educ Couns"},{"key":"973_CR79","doi-asserted-by":"crossref","unstructured":"Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos\u2010Achirica M, Nasir K. Determinants of influenza vaccine uptake in patients with cardiovascular disease and strategies for improvement. J Am Heart Assoc. 2021;10:e019671.","DOI":"10.1161\/JAHA.120.019671"},{"key":"973_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03553-9","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-03553-9.","journal-title":"Nature"},{"key":"973_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00373","author":"A Proal","year":"2018","unstructured":"Proal A, Marshall T. Myalgic encephalomyelitis\/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front Pediatr. 2018. https:\/\/doi.org\/10.3389\/fped.2018.00373.","journal-title":"Front Pediatr"},{"key":"973_CR82","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1016\/j.vaccine.2015.10.018","volume":"33","author":"P Magnus","year":"2015","unstructured":"Magnus P, Gunnes N, Tveito K, Bakken IJ, Ghaderi S, Stoltenberg C, Hornig M, Lipkin WI, Trogstad L, H\u00e5berg SE. Chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33:6173\u20137.","journal-title":"Vaccine"},{"key":"973_CR83","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.2019.16816","volume":"322","author":"J Abbasi","year":"2019","unstructured":"Abbasi J. The search for a universal flu vaccine heats up. JAMA. 2019;322:1942.","journal-title":"JAMA"},{"key":"973_CR84","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/d41586-019-02751-w","volume":"573","author":"M Eisenstein","year":"2019","unstructured":"Eisenstein M. Towards a universal flu vaccine. Nature. 2019;573:S50\u20132.","journal-title":"Nature"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-021-00973-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-021-00973-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-021-00973-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:06:15Z","timestamp":1744146375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-021-00973-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":84,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s11883-021-00973-w","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"2 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Udell has received grant support to his institutions from AstraZeneca, Novartis, and Sanofi; has served as a consultant for Amgen, Boehringer Ingelheim, Janssen, Merck, Novartis, and Sanofi; and has received honoraria from Boehringer Ingelheim and Janssen. All authors have reported that they otherwise have no other relationships relevant to the contents of this paper to disclose and have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources. No endorsement is intended nor should be inferred. Reference to specific commercial products, manufacturers, companies, or trademarks does not constitute its endorsement or recommendation by the U.S. Government, Department of Health and Human Services, or Centers for Disease Control and Prevention and any material referenced here is otherwise available on the agency website for no charge.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"78"}}